Patient characteristics related to metabolic disorders and chronic complications in type 2 diabetes mellitus patients hospitalized at the Qingdao Endocrine and Diabetes Hospital from 2006 to 2012 in China

¹Qingdao Endocrine and Diabetes Hospital;

²Qingdao Endocrine and Diabetes Institute, Qingdao, China;

³R & D information, AstraZeneca;

⁴Medical Evidence and Observational Research, Global Medicine Development, AstraZeneca R&D, Sweden;

⁵Patient Safety, Global Medicine Development, AstraZeneca R&D, Sweden;

⁶Department of Public Health, University of Helsinki, Finland